Olopatadine Hydrochloride Patent Expiration
Olopatadine Hydrochloride is Used for treating allergic conjunctivitis and relieving ocular itching associated with allergic conjunctivitis. It was first introduced by Alcon Laboratories Inc
Olopatadine Hydrochloride Patents
Given below is the list of patents protecting Olopatadine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pataday Once Daily Relief | US8791154 | High concentration olopatadine ophthalmic composition | May 19, 2032 | Alcon Labs Inc |
| Pataday Once Daily Relief | US9533053 | High concentration olopatadine ophthalmic composition | May 19, 2032 | Alcon Labs Inc |
| Pataday Once Daily Relief |
US6995186 (Pediatric) | Olopatadine formulations for topical administration |
May 12, 2024
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief | US6995186 | Olopatadine formulations for topical administration |
Nov 12, 2023
(Expired) | Alcon Labs Inc |
| Patanase |
US7977376 (Pediatric) | Olopatadine formulations for topical nasal administration |
Aug 02, 2023
(Expired) | Novartis |
| Patanase |
US8399508 (Pediatric) | Olopatadine formulations for topical nasal administration |
Mar 17, 2023
(Expired) | Novartis |
| Patanase | US7977376 | Olopatadine formulations for topical nasal administration |
Feb 02, 2023
(Expired) | Novartis |
| Pataday Once Daily Relief |
US7402609 (Pediatric) | Olopatadine formulations for topical administration |
Dec 19, 2022
(Expired) | Alcon Labs Inc |
| Patanase | US8399508 | Olopatadine formulations for topical nasal administration |
Sep 17, 2022
(Expired) | Novartis |
| Pataday Once Daily Relief | US7402609 | Olopatadine formulations for topical administration |
Jun 19, 2022
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief |
US5641805 (Pediatric) | Topical ophthalmic formulations for treating allergic eye diseases |
Dec 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Twice Daily Relief |
US5641805 (Pediatric) | Topical ophthalmic formulations for treating allergic eye diseases |
Dec 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Once Daily Relief | US5641805 | Topical ophthalmic formulations for treating allergic eye diseases |
Jun 06, 2015
(Expired) | Alcon Labs Inc |
| Pataday Twice Daily Relief | US5641805 | Topical ophthalmic formulations for treating allergic eye diseases |
Jun 06, 2015
(Expired) | Alcon Labs Inc |
Olopatadine Hydrochloride's Family Patents
